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Abstract
In the global effort to eliminate lymphatic filariasis (LF), rapid field-applicable tests are useful tools
that will allow on-site testing to be performed in remote places and the results to be obtained
rapidly. Exclusive reliance on the few existing tests may jeopardize the progress of the LF
elimination program, thus the introduction of other rapid tests would be useful to address this
issue. Two new rapid immunochromatographic IgG4 cassette tests have been produced, namely
WB rapid and panLF rapid, for detection of bancroftian filariasis and all three species of lymphatic
filaria respectively. WB rapid was developed using BmSXP recombinant antigen, while PanLF rapid
was developed using BmR1 and BmSXP recombinant antigens. A total of 165 WB rapid and 276
panLF rapid tests respectively were evaluated at USM and the rest were couriered to another
university in Malaysia (98 WB rapid, 129 panLF rapid) and to universities in Indonesia (56 WB rapid,
62 panLF rapid), Japan (152 of each test) and India (18 of each test) where each of the tests
underwent independent evaluations in a blinded manner. The average sensitivities of WB rapid and
panLF rapid were found to be 97.6% (94%–100%) and 96.5% (94%–100%) respectively; while their
average specificities were both 99.6% (99%–100%). Thus this study demonstrated that both the
IgG4 rapid tests were highly sensitive and specific, and would be useful additional tests to facilitate
the global drive to eliminate this disease.
Findings
Diagnostic tools are an essential component for the suc-
cess of the Global Program for Elimination of Lymphatic
Filariasis (GPELF). Thus far, the established diagnostic
tests that are commercially available for bancroftian
filariasis are two antigen detection tests namely NOW
Filariasis Test [1] and Og4C3-ELISA (Trop Bio, Pty. Ltd.,
Australia); and for brugian filariasis is the Brugia Rapid
test [2]. A laboratory-based Bm14-ELISA has also been
extensively employed in studies in Egypt [3,4]. In addition
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PCR-based assays for both brugian and bancroftian
filariasis are also promising tools for the GPELF which can
be employed for monitoring infections in both human
and vector [5,6]. LF mainly affects the poor who reside in
areas which are remote and/or without adequate health
and laboratory facilities. Thus diagnostic tools in the for-
mat of rapid tests, particularly those based on immuno-
chromatography technology, are most suitable to be
employed for the GPELF, since they allow easy on-site
testing, followed by rapid, simple reading and interpreta-
tion of results. These would avoid potential logistical chal-
lenges for sample storage and transportation, as well as
more serious problems such as sample mix-up due to
unclear/unreadable labels and sample degradation that
may occur if collection and performance of tests are not
conducted at the same or nearby locations. For such a
major global program which needs to be sustained for a
prolonged period, availability of a panel of rapid tests
would help ensure smooth progress of the program and
avoid potential problems such as supply interruption and
changes/variations in test performance. Two new rapid
immunochromatographic cassette tests based on detec-
tion of anti-filarial IgG4 antibody are now commercially
available namely WB rapid and panLF rapid. The aim of
this study is to perform a multicentre study to validate the
sensitivities and specificities of the tests.
The test kits were acquired by the senior author from the
manufacturer. A proportion of the tests were validated at
USM, and the rest of the tests were couriered to the other
four participating laboratories. The WB rapid test consists
of two lines namely a test line and a control line, with the
former comprising BmSXP recombinant antigen.
The panLF rapid test consists of three lines namely two
test lines, one comprising BmSXP and the other BmR1
recombinant antigens; and a control line. Goat anti-
mouse IgG antibody is employed as the control line for
both tests. These lines are invisible in an unused test and
are coloured red after performance of the test. Serum/
plasma and whole blood may be employed as test sam-
ples.
For serum samples, the test is performed by delivering 25
ul serum sample into the square bottom well. When the
sample front reaches the blue line on the cassette window,
two drops of buffer are added to a top oval well to release
the conjugate solution (monoclonal anti-human IgG4
conjugated to colloidal gold). This is followed by pulling
a plastic tab at the bottom of the cassette and adding a
drop of buffer into the square bottom well, and by 15
minutes, the results can be read. For both tests, appear-
ance of only the red control line denotes a negative result.
For WB rapid test, a positive result is demonstrated when
two red lines (a test and a control line) are seen. For panLF
rapid test, a test is interpreted as positive when either three
red lines (two test lines and a control line) or two red lines
(a test and a control line) are observed.
Each participating institutions employed serum samples
from their serum bank, which were obtained according to
the ethical requirements of the respective organizations.
With regard to the samples tested in Japan, the sera from
W. bancrofti patients were collected in Sri Lanka, while the
normal sera were from Japanese. The tests were performed
in a blinded manner and the results were collected from
each centre by e-mail attachments.
Table 1 shows the number of the tests and the results
obtained at each institution. WB rapid test displayed an
average sensitivity of 97.6% (239/245), ranging from
94% to 100%. The average overall sensitivity of panLF
rapid test was 96.5% (390/404), ranging from 94% to
100%; the sensitivity for detection of W. bancrofti infec-
tion was 96.0% (217/226) [94% to 100%] while that for
detection of brugian filariasis was 97.2% (173/178) [92%
to 100%]. The specificities of both tests were evaluated
with serum samples from quite a large variety of other
infections, which included helminthes, protozoan, bacte-
rial and viral infections. The results showed that the tests
were either 99% or 100% specific, with an average specif-
icity of 99.6%. Thus, at all the evaluation centres, the sen-
sitivites and specificities of both tests were consistently
high.
The mf+ samples with circulating filarial antigen (CFA), as
determined by Og4C3 assay in samples from Sri Lanka (n
= 41) and India (n = 18), had CFA values > 512 and >1000
respectively. The Sri Lankan mf- samples had CFA values
> 512; with 62/63 (98.4%) and 59/63 (96.7%) samples
positive for WB rapid and panLF rapid respectively. In
addition, the two rapid tests were also tested with samples
from 22 amicrofilaraemic, CFA+ individuals (cryptic
infections) from India which had a wider range of CFA
values (100–4786). In general both rapid tests tested pos-
itive with sera which had CFA units greater than 200, and
they tested negative with sera which had CFA units below
this value. Since CFA may remain positive for sometime
after death of adult worms, some of the mf-, low CFA+
individuals may no longer be actively infected. On the
other hand these may also be individuals with reproduc-
tively immature worms.
In the pre-certification phase of the elimination program
and in the surveillance activities post-elimination, a
highly sensitive test, as displayed by an antibody-based
diagnostic tool is essential since the level of infection, if
any, is very low. Therefore, although a rapid antigen detec-
tion test is already available for bancroftian filariasis, an
antibody detection assay would probably be more usefulFilaria Journal 2007, 6:9 http://www.filariajournal.com/content/6/1/9
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in the screening of young children as required in the pre-
certification phase of GPELF. Antigen detection assays
depend on presence of developmentally mature worms
while antibody assays could potentially detect exposure to
infective larvae by children. Thus WB rapid would be
helpful to address this diagnostic requirement. For detec-
tion of all species of lymphatic filariasis, a rapid test such
as panLF rapid would be very useful in several kinds of sit-
uations, namely testing in areas where there are mixed
bancroftian and brugian filaria infections, in areas where
the infecting species is not known or not confirmed, and
for screening of immigrant workers in countries such as
Malaysia which has more than 1.3 million workers from
filarial endemic countries. These workers may pose a
threat to the achievement of the disease elimination or
they may be a source of resurgence of the disease in the
future.
BmR1 is a recombinant antigen derived from Bm17DIII
gene [GenBank: AF225296] and employed in a rapid test
called Brugia Rapid. It has been shown to be highly sensi-
tive (>95%) and specific (≥ 99%) for detection of B.
malayi and B. timori infections in laboratory evaluations
[7-10] and field studies [11-14]. In a field study in Malay-
sia which is a low endemic area, Brugia Rapid detected
about ten times more positive cases than parasitological
diagnosis, while in the high endemic area of Indonesia,
the increase in detection was about three times [11,12].
Follow-up post-treatment studies of mirofilaraemic indi-
viduals showed that the titres of IgG4 antibodies to BmR1
decreased post-treatment. In Malaysia which is a low
endemic area, it took approximately 6 months to 2 years
post-treatment for the assay to become negative [15,16].
In a study involving a paediatric population in Kerala,
ultrasonography ('filarial dance sign' or FDS) identified
adult worms in 7 out of the 39 (18%) amicrofilaraemic
children who were Brugia Rapid positive, thus providing
definitive evidence that the rapid test detected active infec-
tion. This was comparable to the observation of FDS in 6
out of 32 (19%) microfilaraemic children [17].
BmSXP is a recombinant antigen derived from SXP1 gene
[GenBank no: M98813], the clone was isolated from a B.
malayi adult male worm cDNA library with sera of ban-
croftian filariasis patients [18]. A rapid flow-through IgG
immunofiltration test using WbSXP recombinant antigen
has been developed and a sensitivity of 91% (30/33) was
recorded for detection of W. bancrofti infection [9].
In a recent study, BmSXP was found to be more sensitive
(95%) in detecting W. bancrofti infection as compared to
BmR1 (14%). On the other hand BmR1 was more sensi-
tive than BmSXP in detecting B. malayi infection (98% and
84% respectively) [19]. Since BmR1 and BmSXP recom-
binant antigen cross-reacts with bancroftian and brugian
filaria infection sera respectively, the panLF rapid test is
not useful for species identification. However in the con-
text of GPELF or for screening of foreign workers, this does
not pose a problem. Cross-reactivities with Loa-loa and
Onchocerca infection sera were observed with both rapid
tests, thus they are not useful in areas co-endemic with
these infections. However the tests may be employed in
Table 1: Sensitivities and specificities of WB rapid and panLF rapid tests evaluated at five institutions.
WB rapid panLF rapid
Wb Bm/Bt *Other infec-tions Nor-mals Sens & Spec Wb Bm/Bt *Other 
infections
Normals Sens & Spec
UI 43 (43) - 0 (13) - 100% sens
100% spec
24 (24) 35 (38) - - Overall
sens: 95%
Wb: 100% sens
Bm: 92% sens
UM 30 (30) - 0 (58) 0 (10) 100% sens
100% spec
30 (30) 29 (29) 0 (60) 0 (10) 100% sens (Bm & Wb)
100% spec
AMU 102 (104) - - 0 (48) 98% sens
100% spec
99 (104) - - 0 (48) 95% sens (Wb)
100% spec
USM 47 (50) - 1 (65) 0 (50) 94% sens
99% spec
47 (50) 109 (111) 1 (65) 0 (50) Overall sens: 97%
Wb: 94% sens
Bm: 98% sens
99% spec
ILS 17 (18) - - - 94% sens 17 (18) - - - 94% sens (Wb)
Note: Numbers indicate number of samples that were positive, and numbers in parenthesis were the number of samples tested.
UI : University of Indonesia, Indonesia
UM : University of Malaya, Malaysia
AMU : Aichii Medical University, Japan
USM : Universiti Sains Malaysia, Malaysia
ILS : Institute of Life Sciences, India
sens : sensitivity; spec : specificity
Wb: Wuchereria bancrofti ; Bm: Brugia malayi ; Bt: Brugia timori
Filarial samples tested in Indonesia, Malaysia and India came from mf+ individuals; while those tested in Japan also came from individuals who are mf-, CFA+ (>512 units).
*Other infections: ascariasis, trichuriasis, hookworm, strongyloidiasis, toxocariasis, toxoplasmosis, typhoid, cysticercosis, schistosomiasis, malaria, dengue, amoebiasis
WB rapid: sensitivity : 97.6% (239/245); specificity : 99.6% (243/244)
panLF rapid: overall sensitivity : 96.5% (390/404); sensitivity for Wb detection: 96.0% (217/226); sensitivity for Bm/Bt detection: 97.2% (173/178); specificity: 99.6% (232/233)Filaria Journal 2007, 6:9 http://www.filariajournal.com/content/6/1/9
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the vast lymphatic filariasis endemic areas in the world,
particularly in Asia, which do not overlap with endemic
areas for non-lymphatic filariasis. Since LF endemic areas
are also prevalent for infections with soil-transmitted
helminthes and intestinal protozoa, the high specificities
shown by both rapid tests with respect to non-filarial
infections would allow the tests to be used with high con-
fidence in these areas.
In conclusion, the present multicentre evaluation study
conducted in five institutions (located in four different
countries) clearly demonstrated the high sensitivities and
specificities of WB rapid and panLF rapid tests. Thus these
tests should be employed in further field studies and
would merit consideration as potential tools to assist in
the GPELF.
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